Results 271 to 280 of about 305,892 (307)

Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation. [PDF]

Kidney Int Rep
Barratt J, Garred P, Lafayette RA, Zhang H, Floege J.   +4 more
europepmc   +1 more source

Synthetic Nanobiology Actuated Lipometabolic Cell Factory for Autologous Tumor Immunotherapy

Advanced Functional Materials, EarlyView.
FA plays a crucial role in the interaction between tumor cells and the tumor microenvironment, especially for the immune response. A biocatalytic immunoenhancement strategy is developed to boost antitumor immunity by FA metabolic orientation to ceramide. Through the design of this delicate catalytic immunoenhancement strategy, the synthetic nanobiology
Shoujie Zhao, Yejing Zhu, Hengchao Yu, Jun Zhu, Bo Wang, Yu Qiao, Zhimin Tian, Junlong Zhao, Lei Liu   +8 more
wiley   +1 more source

Diagnosis and treatment of complement-mediated thrombotic microangiopathies: consensus of the Genetic Diseases Committee of the Chilean Society of Nephrology. [PDF]

BMC Nephrol
Musalem P, Bascur N, Sepúlveda RA, Krall P, Lazcano A, Navarro G, Rojo A, Grandy J.   +7 more
europepmc   +1 more source

Organ Transplantation: Current Status, Challenges, and Future Prospects. [PDF]

MedComm (2020)
Li X, Ding R, Cai J.
europepmc   +1 more source

Serum proteomic profiling reveals immune and inflammatory mechanisms driving susceptibility to buffalo fly-induced skin lesions in cattle. [PDF]

Sci Rep
Raza A, Naseem MN, Kamran M, Nouwens A, Juli MSB, Constantinoiu C, Tabor A, Schulz B, James P.   +8 more
europepmc   +1 more source

GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling. [PDF]

Eur Heart J Open
Samaranayake CB, Chen YC, Fang M, Rhodes CJ, Song S, Sabrin F, Ashek A, Bonnici K, Mukherjee B, Howard LS, Pinguel J, Rawal B, Semple T, Price LC, Wort SJ, Rudd T, Zhao L, McCabe C.   +17 more
europepmc   +1 more source

Immune-mediated blood-brain barrier disruption after ischemic stroke: mechanisms and therapeutic targets. [PDF]

Front Immunol
Wang H, Yiqiang Z, Cai J, Guo J.
europepmc   +1 more source

Effect of curcumin on mutant H-factor secretion in a deficient patient of this complement regulatory system protein.

, 2018
Ana Catarina Lunz Macedo
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Viral complement regulatory proteins

Immunopharmacology, 1999
The inactivation of complement provides cells and tissues critical protection from complement-mediated attack and decreases the associated recruitment of other inflammatory mediators. In an attempt to evade the host immune response, viruses have evolved two mechanisms to acquire complement regulatory proteins.
A M, Rosengard, J M, Ahearn
openaire   +2 more sources